Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: Receptors, functions, and roles in diseases

Journal of Allergy and Clinical Immunology

Volumn 138, Issue 4, 2016, Pages 984-1010

  Akdis, Mübeccel ^a   Aab, Alar ^a   Altunbulakli, Can ^a   Azkur, Kursat ^a   Costa, Rita A ^a   Crameri, Reto ^a   Duan, Su ^a   Eiwegger, Thomas ^a   Eljaszewicz, Andrzej ^a   Ferstl, Ruth ^a   Frei, Remo ^a   Garbani, Mattia ^a   Globinska, Anna ^a   Hess, Lena ^a   Huitema, Carly ^a   Kubo, Terufumi ^a   Komlosi, Zsolt ^a   Konieczna, Patricia ^a   Kovacs, Nora ^a   Kucuksezer, Umut C ^a   Meyer, Norbert ^a   Morita, Hideaki ^a   Olzhausen, Judith ^a   O'Mahony, Liam ^a   Pezer, Marija ^a   Prati, Moira ^a   Rebane, Ana ^a   Rhyner, Claudio ^a   Rinaldi, Arturo ^a   Sokolowska, Milena ^a   Stanic, Barbara ^a   Sugita, Kazunari ^a   Treis, Angela ^a   van de Veen, Willem ^a   Wanke, Kerstin ^a   Wawrzyniak, Marcin ^a   Wawrzyniak, Paulina ^a   Wirz, Oliver F ^a   Zakzuk, Josefina Sierra ^a   Akdis, Cezmi A ^a   more..

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

adaptive immune response; allergy and asthma; B cells; Cytokines; dendritic cells; humoral immune response; innate immune response; interleukins; T cells

Indexed keywords

GAMMA INTERFERON; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 19; INTERLEUKIN 2; INTERLEUKIN 20; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 24; INTERLEUKIN 3; INTERLEUKIN 33; INTERLEUKIN 36; INTERLEUKIN 37; INTERLEUKIN 38; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 9; INTERLEUKIN DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; IL-38 PROTEIN, HUMAN;

ALLERGY; ASTHMA; BASOPHIL; CD4+ T LYMPHOCYTE; CELL INTERACTION; CELL SUBPOPULATION; CHRONIC DISEASE; DNA POLYMORPHISM; EFFECTOR CELL; EPITHELIUM CELL; GENE MUTATION; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; INFLAMMATORY CELL; INFLAMMATORY DISEASE; MAST CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; IMMUNOLOGY; IMMUNOPATHOLOGY; PHYSIOLOGY;

ANIMALS; HUMANS; IMMUNE SYSTEM DISEASES; INTERFERONS; INTERLEUKINS; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84992195167     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2016.06.033     Document Type: Review

References (218)

1. 1 Dinarello, C., Arend, W., Sims, J., Smith, D., Blumberg, H., O'Neill, L., et al. IL-1 family nomenclature. Nat Immunol, 11, 2010, 973.
2. 2 Lloyd, C.M., Saglani, S., T cells in asthma: influences of genetics, environment, and T-cell plasticity. J Allergy Clin Immunol 131 (2013), 1267–1274.
3. 3 Akdis, M., Burgler, S., Crameri, R., Eiwegger, T., Fujita, H., Gomez, E., et al. Interleukins, from 1 to 37, and interferon-gamma: receptors, functions, and roles in diseases. J Allergy Clin Immunol 127 (2011), 701–721 e1-70.
4. 4 Akdis, M., Akdis, C.A., Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens. J Allergy Clin Immunol 133 (2014), 621–631.
5. 5 Annunziato, F., Romagnani, C., Romagnani, S., The 3 major types of innate and adaptive cell-mediated effector immunity. J Allergy Clin Immunol 135 (2015), 626–635.
6. 6 Christianson, C.A., Goplen, N.P., Zafar, I., Irvin, C., Good, J.T. Jr., Rollins, D.R., et al. Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33. J Allergy Clin Immunol 136 (2015), 59–68.e14.
7. 7 Sharma, S., Zhou, X., Thibault, D.M., Himes, B.E., Liu, A., Szefler, S.J., et al. A genome-wide survey of CD4(+) lymphocyte regulatory genetic variants identifies novel asthma genes. J Allergy Clin Immunol 134 (2014), 1153–1162.
8. 8 Vickery, B.P., Scurlock, A.M., Kulis, M., Steele, P.H., Kamilaris, J., Berglund, J.P., et al. Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. J Allergy Clin Immunol 133 (2014), 468–475.
9. 9 Hinks, T.S., Zhou, X., Staples, K.J., Dimitrov, B.D., Manta, A., Petrossian, T., et al. Innate and adaptive T cells in asthmatic patients: relationship to severity and disease mechanisms. J Allergy Clin Immunol 136 (2015), 323–333.
10. 10 Gold, M.J., Antignano, F., Halim, T.Y., Hirota, J.A., Blanchet, M.R., Zaph, C., et al. Group 2 innate lymphoid cells facilitate sensitization to local, but not systemic, TH2-inducing allergen exposures. J Allergy Clin Immunol 133 (2014), 1142–1148.
11. 11 Akdis, M., Healthy immune response to allergens: T regulatory cells and more. Curr Opin Immunol 18 (2006), 738–744.
12. 12 Kang, C.M., Jang, A.S., Ahn, M.H., Shin, J.A., Kim, J.H., Choi, Y.S., et al. Interleukin-25 and interleukin-13 production by alveolar macrophages in response to particles. Am J Respir Cell Mol Biol 33 (2005), 290–296.
13. 13 Dillon, S.R., Sprecher, C., Hammond, A., Bilsborough, J., Rosenfeld-Franklin, M., Presnell, S.R., et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 5 (2004), 752–760.
14. 14 Morita, H., Arae, K., Unno, H., Miyauchi, K., Toyama, S., Nambu, A., et al. An interleukin-33-mast cell-interleukin-2 axis suppresses papain-induced allergic inflammation by promoting regulatory T cell numbers. Immunity 43 (2015), 175–186.
15. 15 Soyka, M.B., Wawrzyniak, P., Eiwegger, T., Holzmann, D., Treis, A., Wanke, K., et al. Defective epithelial barrier in chronic rhinosinusitis: The regulation of tight junctions by IFN-gamma and IL-4. J Allergy Clin Immunol 130 (2012), 1087–1096.
16. 16 Kubo, T., Wawrzyniak, P., Morita, H., Sugita, K., Wanke, K., Kast, J.I., et al. CpG-DNA enhances the tight junction integrity of the bronchial epithelial cell barrier. J Allergy Clin Immunol 136 (2015), 1413–1416 e1-8.
17. 17 Seltmann, J., Roesner, L.M., von Hesler, F.W., Wittmann, M., Werfel, T., IL-33 impacts on the skin barrier by downregulating the expression of filaggrin. J Allergy Clin Immunol 135 (2015), 1659–1661.e4.
18. 18 Georas, S.N., Rezaee, F., Epithelial barrier function: at the front line of asthma immunology and allergic airway inflammation. J Allergy Clin Immunol 134 (2014), 509–520.
19. 19 Smits, H.H., Akdis, C.A., In utero priming by worms protects against respiratory allergies. J Allergy Clin Immunol 134 (2014), 1280–1281.
20. 20 Akkoc, T., de Koning, P.J., Ruckert, B., Barlan, I., Akdis, M., Akdis, C.A., Increased activation-induced cell death of high IFN-gamma-producing T(H)1 cells as a mechanism of T(H)2 predominance in atopic diseases. J Allergy Clin Immunol 121 (2008), 652–658.e1.
21. 21 Yoo, J.K., Kim, T.S., Hufford, M.M., Braciale, T.J., Viral infection of the lung: host response and sequelae. J Allergy Clin Immunol 132 (2013), 1263–1277.
22. 22 Rebane, A., Zimmermann, M., Aab, A., Baurecht, H., Koreck, A., Karelson, M., et al. Mechanisms of IFN-gamma-induced apoptosis of human skin keratinocytes in patients with atopic dermatitis. J Allergy Clin Immunol 129 (2012), 1297–1306.
23. 23 Harrington, L.E., Hatton, R.D., Mangan, P.R., Turner, H., Murphy, T.L., Murphy, K.M., et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6 (2005), 1123–1132.
24. 24 Akdis, M., Palomares, O., van de Veen, W., van Splunter, M., Akdis, C.A., TH17 and TH22 cells: a confusion of antimicrobial response with tissue inflammation versus protection. J Allergy Clin Immunol 129 (2012), 1438–1449.
25. 25 Wawrzyniak, M., Ochsner, U., Wirz, O., Wawrzyniak, P., van de Veen, W., Akdis, C.A., et al. A novel, dual cytokine-secretion assay for the purification of human Th22 cells that do not co-produce IL-17A. Allergy 71 (2016), 47–57.
26. 26 Sehra, S., Yao, W., Nguyen, E.T., Glosson-Byers, N.L., Akhtar, N., Zhou, B., et al. TH9 cells are required for tissue mast cell accumulation during allergic inflammation. J Allergy Clin Immunol 136 (2015), 433–440.e1.
27. 27 Brough, H.A., Cousins, D.J., Munteanu, A., Wong, Y.F., Sudra, A., Makinson, K., et al. IL-9 is a key component of memory TH cell peanut-specific responses from children with peanut allergy. J Allergy Clin Immunol 134 (2014), 1329–1338.e10.
28. 28 King, C., Tangye, S.G., Mackay, C.R., T follicular helper (TFH) cells in normal and dysregulated immune responses. Annu Rev Immunol 26 (2008), 741–766.
29. 29 de Wit, J., Jorritsma, T., Makuch, M., Remmerswaal, E.B., Klaasse Bos, H., Souwer, Y., et al. Human B cells promote T-cell plasticity to optimize antibody response by inducing coexpression of T(H)1/T(FH) signatures. J Allergy Clin Immunol 135 (2015), 1053–1060.
30. 30 Akdis, M., Akdis, C.A., Therapeutic manipulation of immune tolerance in allergic disease. Nat Rev Drug Discov 8 (2009), 645–660.
31. 31 Raedler, D., Ballenberger, N., Klucker, E., Bock, A., Otto, R., Prazeres da Costa, O., et al. Identification of novel immune phenotypes for allergic and nonallergic childhood asthma. J Allergy Clin Immunol 135 (2015), 81–91.
32. 32 Suarez-Fueyo, A., Ramos, T., Galan, A., Jimeno, L., Wurtzen, P.A., Marin, A., et al. Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation. J Allergy Clin Immunol 133 (2014), 130–138 e1-2.
33. 33 Fox, E.M., Torrero, M.N., Evans, H., Mitre, E., Immunologic characterization of 3 murine regimens of allergen-specific immunotherapy. J Allergy Clin Immunol 135 (2015), 1341–1351 e1-7.
34. 34 Akdis, C.A., Akdis, M., Advances in allergen immunotherapy: aiming for complete tolerance to allergens. Sci Transl Med, 7, 2015, 280ps6.
35. 35 Stanic, B., van de Veen, W., Wirz, O.F., Ruckert, B., Morita, H., Sollner, S., et al. IL-10-overexpressing B cells regulate innate and adaptive immune responses. J Allergy Clin Immunol 135 (2015), 771–780.e8.
36. 36 Doherty, T.A., Baum, R., Newbury, R.O., Yang, T., Dohil, R., Aquino, M., et al. Group 2 innate lymphocytes (ILC2) are enriched in active eosinophilic esophagitis. J Allergy Clin Immunol 136 (2015), 792–794.e3.
37. 37 Nagakumar, P., Denney, L., Fleming, L., Bush, A., Lloyd, C.M., Saglani, S., Type 2 innate lymphoid cells in induced sputum from children with severe asthma. J Allergy Clin Immunol 137 (2016), 624–626.e6.
38. 38 Harvima, I.T., Levi-Schaffer, F., Draber, P., Friedman, S., Polakovicova, I., Gibbs, B.F., et al. Molecular targets on mast cells and basophils for novel therapies. J Allergy Clin Immunol 134 (2014), 530–544.
39. 39 Siracusa, M.C., Kim, B.S., Spergel, J.M., Artis, D., Basophils and allergic inflammation. J Allergy Clin Immunol 132 (2013), 789–801.
40. 40 Munoz-Cano, R., Pascal, M., Bartra, J., Picado, C., Valero, A., Kim, D.K., et al. Distinct transcriptome profiles differentiate nonsteroidal anti-inflammatory drug-dependent from nonsteroidal anti-inflammatory drug-independent food-induced anaphylaxis. J Allergy Clin Immunol 137 (2016), 137–146.
41. 41 Hammad, H., Lambrecht, B.N., Barrier epithelial cells and the control of type 2 immunity. Immunity 43 (2015), 29–40.
42. 42 Schuijs, M.J., Willart, M.A., Vergote, K., Gras, D., Deswarte, K., Ege, M.J., et al. Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells. Science 349 (2015), 1106–1110.
43. 43 Lambrecht, B.N., Hammad, H., The immunology of asthma. Nat Immunol 16 (2015), 45–56.
44. 44 Vareille, M., Kieninger, E., Edwards, M.R., Regamey, N., The airway epithelium: soldier in the fight against respiratory viruses. Clin Microbiol Rev 24 (2011), 210–229.
45. 45 Bauer, R.N., Manohar, M., Singh, A.M., Jay, D.C., Nadeau, K.C., The future of biologics: applications for food allergy. J Allergy Clin Immunol 135 (2015), 312–323.
46. 46 Ortega, V.E., Meyers, D.A., Pharmacogenetics: implications of race and ethnicity on defining genetic profiles for personalized medicine. J Allergy Clin Immunol 133 (2014), 16–26.
47. 47 Anderson, W.C. 3rd, Szefler, S.J., New and future strategies to improve asthma control in children. J Allergy Clin Immunol 136 (2015), 848–859.
48. 48 Agache, I., Sugita, K., Morita, H., Akdis, M., Akdis, C.A., The complex type 2 endotype in allergy and asthma: from laboratory to bedside. Curr Allergy Asthma Rep, 15, 2015, 29.
49. 49 Akdis, C.A., Bachert, C., Cingi, C., Dykewicz, M.S., Hellings, P.W., Naclerio, R.M., et al. Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol 131 (2013), 1479–1490.
50. 50 Hennig, C., Ilginus, C., Boztug, K., Skokowa, J., Marodi, L., Szaflarska, A., et al. High-content cytometry and transcriptomic biomarker profiling of human B-cell activation. J Allergy Clin Immunol 133 (2014), 172–180 e1-10.
51. 51 Dinarello, C.A., Renfer, L., Wolff, S.M., Human leukocytic pyrogen: purification and development of a radioimmunoassay. Proc Natl Acad Sci U S A 74 (1977), 4624–4627.
52. 52 Eisenberg, S.P., Evans, R.J., Arend, W.P., Verderber, E., Brewer, M.T., Hannum, C.H., et al. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 343 (1990), 341–346.
53. 53 Garlanda, C., Dinarello, C.A., Mantovani, A., The interleukin-1 family: back to the future. Immunity 39 (2013), 1003–1018.
54. 54 Guo, H., Callaway, J.B., Ting, J.P., Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med 21 (2015), 677–687.
55. 55 Hernandez, M.L., Mills, K., Almond, M., Todoric, K., Aleman, M.M., Zhang, H., et al. IL-1 receptor antagonist reduces endotoxin-induced airway inflammation in healthy volunteers. J Allergy Clin Immunol 135 (2015), 379–385.
56. 56 Coll, R.C., Robertson, A.A., Chae, J.J., Higgins, S.C., Munoz-Planillo, R., Inserra, M.C., et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med 21 (2015), 248–255.
57. 57 Sokolowska, M., Chen, L.Y., Liu, Y., Martinez-Anton, A., Qi, H.Y., Logun, C., et al. Prostaglandin E2 Inhibits NLRP3 Inflammasome Activation through EP4 Receptor and Intracellular Cyclic AMP in Human Macrophages. J Immunol 194 (2015), 5472–5487.
58. 58 Okamura, H., Tsutsi, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378 (1995), 88–91.
59. 59 Nold-Petry, C.A., Lo, C.Y., Rudloff, I., Elgass, K.D., Li, S., Gantier, M.P., et al. IL-37 requires the receptors IL-18Ralpha and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction. Nat Immunol 16 (2015), 354–365.
60. 60 Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T.K., et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23 (2005), 479–490.
61. 61 Licona-Limon, P., Kim, L.K., Palm, N.W., Flavell, R.A., TH2, allergy and group 2 innate lymphoid cells. Nat Immunol 14 (2013), 536–542.
62. 62 Savenije, O.E., Mahachie John, J.M., Granell, R., Kerkhof, M., Dijk, F.N., de Jongste, J.C., et al. Association of IL33-IL-1 receptor-like 1 (IL1RL1) pathway polymorphisms with wheezing phenotypes and asthma in childhood. J Allergy Clin Immunol 134 (2014), 170–177.
63. 63 Mehta, A.K., Duan, W., Doerner, A.M., Traves, S.L., Broide, D.H., Proud, D., et al. Rhinovirus infection interferes with induction of tolerance to aeroantigens through OX40 ligand, thymic stromal lymphopoietin, and IL-33. J Allergy Clin Immunol 137 (2016), 278–288.e6.
64. 64 Shaik, Y., Sabatino, G., Maccauro, G., Varvara, G., Murmura, G., Saggini, A., et al. IL-36 receptor antagonist with special emphasis on IL-38. Int J Immunopathol Pharmacol 26 (2013), 27–36.
65. 65 Suarez-Farinas, M., Ungar, B., Correa da Rosa, J., Ewald, D.A., Rozenblit, M., Gonzalez, J., et al. RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications. J Allergy Clin Immunol 135 (2015), 1218–1227.
66. 66 Bufler, P., Azam, T., Gamboni-Robertson, F., Reznikov, L.L., Kumar, S., Dinarello, C.A., et al. A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity. Proc Natl Acad Sci U S A 99 (2002), 13723–13728.
67. 67 Nold, M.F., Nold-Petry, C.A., Zepp, J.A., Palmer, B.E., Bufler, P., Dinarello, C.A., IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol 11 (2010), 1014–1022.
68. 68 Palomo, J., Dietrich, D., Martin, P., Palmer, G., Gabay, C., The interleukin (IL)-1 cytokine family—balance between agonists and antagonists in inflammatory diseases. Cytokine 6 (2015), 25–37.
69. 69 Yamane, H., Paul, W.E., Cytokines of the gamma(c) family control CD4+ T cell differentiation and function. Nat Immunol 13 (2012), 1037–1044.
70. 70 Morgan, D.A., Ruscetti, F.W., Gallo, R., Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 193 (1976), 1007–1008.
71. 71 van de Veen, W., Stanic, B., Yaman, G., Wawrzyniak, M., Sollner, S., Akdis, D.G., et al. IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses. J Allergy Clin Immunol 131 (2013), 1204–1212.
72. 72 Wegrzyn, A.S., Jakiela, B., Ruckert, B., Jutel, M., Akdis, M., Sanak, M., et al. T-cell regulation during viral and nonviral asthma exacerbations. J Allergy Clin Immunol 36 (2015), 194–197.
73. 73 Roediger, B., Kyle, R., Tay, S.S., Mitchell, A.J., Bolton, H.A., Guy, T.V., et al. IL-2 is a critical regulator of group 2 innate lymphoid cell function during pulmonary inflammation. J Allergy Clin Immunol 136 (2015), 1653–1663.
74. 74 Howard, M., Farrar, J., Hilfiker, M., Johnson, B., Takatsu, K., Hamaoka, T., et al. Identification of a T cell-derived B cell growth factor distinct from interleukin 2. J Exp Med 155 (1982), 914–923.
75. 75 Chung, K.F., Targeting the interleukin pathway in the treatment of asthma. Lancet 386 (2015), 1086–1096.
76. 76 Wang, X., Lupardus, P., Laporte, S.L., Garcia, K.C., Structural biology of shared cytokine receptors. Annu Rev Immunol 27 (2009), 29–60.
77. 77 Boudil, A., Matei, I.R., Shih, H.Y., Bogdanoski, G., Yuan, J.S., Chang, S.G., et al. IL-7 coordinates proliferation, differentiation and Tcra recombination during thymocyte beta-selection. Nat Immunol 16 (2015), 397–405.
78. 78 Uyttenhove, C., Coulie, P.G., Van Snick, J., T cell growth and differentiation induced by interleukin-HP1/IL-6, the murine hybridoma/plasmacytoma growth factor. J Exp Med 167 (1988), 1417–1427.
79. 79 Veldhoen, M., Uyttenhove, C., van Snick, J., Helmby, H., Westendorf, A., Buer, J., et al. Transforming growth factor-beta ‘reprograms’ the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 9 (2008), 1341–1346.
80. 80 Liu, J., Harberts, E., Tammaro, A., Girardi, N., Filler, R.B., Fishelevich, R., et al. IL-9 regulates allergen-specific Th1 responses in allergic contact dermatitis. J Invest Dermatol 134 (2014), 1903–1911.
81. 81 Grabstein, K.H., Eisenman, J., Shanebeck, K., Rauch, C., Srinivasan, S., Fung, V., et al. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 264 (1994), 965–968.
82. 82 Ikemizu, S., Chirifu, M., Davis, S.J., IL-2 and IL-15 signaling complexes: different but the same. Nat Immunol 13 (2012), 1141–1142.
83. 83 Rutz, S., Wang, X., Ouyang, W., The IL-20 subfamily of cytokines—from host defence to tissue homeostasis. Nat Rev Immunol 14 (2014), 783–795.
84. 84 Oral, H.B., Kotenko, S.V., Yilmaz, M., Mani, O., Zumkehr, J., Blaser, K., et al. Regulation of T cells and cytokines by the interleukin-10 (IL-10)-family cytokines IL-19, IL-20, IL-22, IL-24 and IL-26. Eur J Immunol 36 (2006), 380–388.
85. 85 Jin, G., Hamaguchi, Y., Matsushita, T., Hasegawa, M., Le Huu, D., Ishiura, N., et al. B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells. J Allergy Clin Immunol 131 (2013), 1674–1682.
86. 86 Meiler, F., Zumkehr, J., Klunker, S., Ruckert, B., Akdis, C.A., Akdis, M., In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J Exp Med 205 (2008), 2887–2898.
87. 87 Palomares, O., Martin-Fontecha, M., Lauener, R., Traidl-Hoffmann, C., Cavkaytar, O., Akdis, M., et al. Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-beta. Genes Immun 15 (2014), 511–520.
88. 88 Akdis, C.A., Akdis, M., Mechanisms of immune tolerance to allergens: role of IL-10 and Tregs. J Clin Invest 124 (2014), 4678–4680.
89. 89 Engelhardt, K.R., Shah, N., Faizura-Yeop, I., Kocacik Uygun, D.F., Frede, N., Muise, A.M., et al. Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation. J Allergy Clin Immunol 131 (2013), 825–830.
90. 90 Figueiredo, C.A., Barreto, M.L., Alcantara-Neves, N.M., Rodrigues, L.C., Cooper, P.J., Cruz, A.A., et al. Coassociations between IL10 polymorphisms, IL-10 production, helminth infection, and asthma/wheeze in an urban tropical population in Brazil. J Allergy Clin Immunol 131 (2013), 1683–1690.
91. 91 Gallagher, G., Dickensheets, H., Eskdale, J., Izotova, L.S., Mirochnitchenko, O.V., Peat, J.D., et al. Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10). Genes Immun 1 (2000), 442–450.
92. 92 Myles, I.A., Fontecilla, N.M., Valdez, P.A., Vithayathil, P.J., Naik, S., Belkaid, Y., et al. Signaling via the IL-20 receptor inhibits cutaneous production of IL-1beta and IL-17A to promote infection with methicillin-resistant Staphylococcus aureus. Nat Immunol 14 (2013), 804–811.
93. 93 Blumberg, H., Conklin, D., Xu, W., Grossmann, A., Brender, T., Carollo, S., et al. Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell 104 (2001), 9–19.
94. 94 Mashiko, S., Bouguermouh, S., Rubio, M., Baba, N., Bissonnette, R., Sarfati, M., Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis. J Allergy Clin Immunol 136 (2015), 351–359.e1.
95. 95 Zheng, Y., Danilenko, D.M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J., et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445 (2007), 648–651.
96. 96 Sugimoto, K., Ogawa, A., Mizoguchi, E., Shimomura, Y., Andoh, A., Bhan, A.K., et al. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest 118 (2008), 534–544.
97. 97 Eyerich, S., Eyerich, K., Pennino, D., Carbone, T., Nasorri, F., Pallotta, S., et al. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 119 (2009), 3573–3585.
98. 98 Pennino, D., Bhavsar, P.K., Effner, R., Avitabile, S., Venn, P., Quaranta, M., et al. IL-22 suppresses IFN-gamma-mediated lung inflammation in asthmatic patients. J Allergy Clin Immunol 131 (2013), 562–570.
99. 99 Teraki, Y., Sakurai, A., Izaki, S., IL-13/IL-22-coproducing T cells, a novel subset, are increased in atopic dermatitis. J Allergy Clin Immunol 132 (2013), 971–974.
100. 100 Hernandez, P.P., Mahlakoiv, T., Yang, I., Schwierzeck, V., Nguyen, N., Guendel, F., et al. Interferon-lambda and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of rotavirus infection. Nat Immunol 16 (2015), 698–707.
101. 101 Jiang, H., Lin, J.J., Su, Z.Z., Goldstein, N.I., Fisher, P.B., Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene 11 (1995), 2477–2486.
102. 102 Wang, M., Tan, Z., Zhang, R., Kotenko, S.V., Liang, P., Interleukin 24 (MDA-7/MOB-5) signals through two heterodimeric receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2. J Biol Chem 277 (2002), 7341–7347.
103. 103 Panneerselvam, J., Shanker, M., Jin, J., Branch, C.D., Muralidharan, R., Zhao, Y.D., et al. Phosphorylation of interleukin (IL)-24 is required for mediating its anti-cancer activity. Oncotarget 6 (2015), 16271–16286.
104. 104 Tong, A.W., Nemunaitis, J., Su, D., Zhang, Y., Cunningham, C., Senzer, N., et al. Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patients. Mol Ther 11 (2005), 160–172.
105. 105 Shefler, I., Pasmanik-Chor, M., Kidron, D., Mekori, Y.A., Hershko, A.Y., T cell-derived microvesicles induce mast cell production of IL-24: relevance to inflammatory skin diseases. J Allergy Clin Immunol 133 (2014), 217–224 e1-3.
106. 106 Knappe, A., Hor, S., Wittmann, S., Fickenscher, H., Induction of a novel cellular homolog of interleukin-10, AK155, by transformation of T lymphocytes with herpesvirus saimiri. J Virol 74 (2000), 3881–3887.
107. 107 Wilson, N.J., Boniface, K., Chan, J.R., McKenzie, B.S., Blumenschein, W.M., Mattson, J.D., et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8 (2007), 950–957.
108. 108 Hor, S., Pirzer, H., Dumoutier, L., Bauer, F., Wittmann, S., Sticht, H., et al. The T-cell lymphokine interleukin-26 targets epithelial cells through the interleukin-20 receptor 1 and interleukin-10 receptor 2 chains. J Biol Chem 279 (2004), 33343–33351.
109. 109 Meller, S., Di Domizio, J., Voo, K.S., Friedrich, H.C., Chamilos, G., Ganguly, D., et al. TH17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26. Nat Immunol 16 (2015), 970–979.
110. 110 Sheppard, P., Kindsvogel, W., Xu, W., Henderson, K., Schlutsmeyer, S., Whitmore, T.E., et al. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 4 (2003), 63–68.
111. 111 Prokunina-Olsson, L., Muchmore, B., Tang, W., Pfeiffer, R.M., Park, H., Dickensheets, H., et al. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet 45 (2013), 164–171.
112. 112 Robek, M.D., Boyd, B.S., Chisari, F.V., Lambda interferon inhibits hepatitis B and C virus replication. J Virol 79 (2005), 3851–3854.
113. 113 Mennechet, F.J., Uze, G., Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells. Blood 107 (2006), 4417–4423.
114. 114 Kobayashi, M., Fitz, L., Ryan, M., Hewick, R.M., Clark, S.C., Chan, S., et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 170 (1989), 827–845.
115. 115 Jones, L.L., Chaturvedi, V., Uyttenhove, C., Van Snick, J., Vignali, D.A., Distinct subunit pairing criteria within the heterodimeric IL-12 cytokine family. Mol Immunol 51 (2012), 234–244.
116. 116 Serafini, N., Vosshenrich, C.A., Di Santo, J.P., Transcriptional regulation of innate lymphoid cell fate. Nat Rev Immunol 15 (2015), 415–428.
117. 117 Hsieh, C.S., Macatonia, S.E., Tripp, C.S., Wolf, S.F., O'Garra, A., Murphy, K.M., Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260 (1993), 547–549.
118. 118 Lemoine, S., Jaron, B., Tabka, S., Ettreiki, C., Deriaud, E., Zhivaki, D., et al. Dectin-1 activation unlocks IL12A expression and reveals the T1 potency of neonatal dendritic cells. J Allergy Clin Immunol 136 (2015), 1355–1368.
119. 119 Shafiani, S., Dinh, C., Ertelt, J.M., Moguche, A.O., Siddiqui, I., Smigiel, K.S., et al. Pathogen-specific Treg cells expand early during mycobacterium tuberculosis infection but are later eliminated in response to Interleukin-12. Immunity 38 (2013), 1261–1270.
120. 120 Parham, C., Chirica, M., Timans, J., Vaisberg, E., Travis, M., Cheung, J., et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol 168 (2002), 5699–5708.
121. 121 Buonocore, S., Ahern, P.P., Uhlig, H.H., Ivanov II, Littman, D.R., Maloy, K.J., et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464 (2010), 1371–1375.
122. 122 Suarez-Farinas, M., Ungar, B., Noda, S., Shroff, A., Mansouri, Y., Fuentes-Duculan, J., et al. Alopecia areata profiling shows T1, T2, and IL-23 cytokine activation without parallel T17/T22 skewing. J Allergy Clin Immunol 136 (2015), 1277–1287.
123. 123 Pflanz, S., Timans, J.C., Cheung, J., Rosales, R., Kanzler, H., Gilbert, J., et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 16 (2002), 779–790.
124. 124 Lucas, S., Ghilardi, N., Li, J., de Sauvage, F.J., IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms. Proc Natl Acad Sci U S A 100 (2003), 15047–15052.
125. 125 Batten, M., Li, J., Yi, S., Kljavin, N.M., Danilenko, D.M., Lucas, S., et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 7 (2006), 929–936.
126. 126 Ouaked, N., Mantel, P.Y., Bassin, C., Burgler, S., Siegmund, K., Akdis, C.A., et al. Regulation of the foxp3 gene by the Th1 cytokines: the role of IL-27-induced STAT1. J Immunol 182 (2009), 1041–1049.
127. 127 Tsoumakidou, M., Tousa, S., Semitekolou, M., Panagiotou, P., Panagiotou, A., Morianos, I., et al. Tolerogenic signaling by pulmonary CD1c+ dendritic cells induces regulatory T cells in patients with chronic obstructive pulmonary disease by IL-27/IL-10/inducible costimulator ligand. J Allergy Clin Immunol 134 (2014), 944–954.e8.
128. 128 Xie, M., Mustovich, A.T., Jiang, Y., Trudeau, J.B., Ray, A., Ray, P., et al. IL-27 and type 2 immunity in asthmatic patients: association with severity, CXCL9, and signal transducer and activator of transcription signaling. J Allergy Clin Immunol 135 (2015), 386–394.
129. 129 Ziblat, A., Domaica, C.I., Spallanzani, R.G., Iraolagoitia, X.L., Rossi, L.E., Avila, D.E., et al. IL-27 stimulates human NK-cell effector functions and primes NK cells for IL-18 responsiveness. Eur J Immunol 45 (2015), 192–202.
130. 130 Mascanfroni, I.D., Yeste, A., Vieira, S.M., Burns, E.J., Patel, B., Sloma, I., et al. IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39. Nat Immunol 14 (2013), 1054–1063.
131. 131 Di Carlo, E., Sorrentino, C., Zorzoli, A., Di Meo, S., Tupone, M.G., Ognio, E., et al. The antitumor potential of Interleukin-27 in prostate cancer. Oncotarget 5 (2014), 10332–10341.
132. 132 Devergne, O., Birkenbach, M., Kieff, E., Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc Natl Acad Sci U S A 94 (1997), 12041–12046.
133. 133 Collison, L.W., Workman, C.J., Kuo, T.T., Boyd, K., Wang, Y., Vignali, K.M., et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450 (2007), 566–569.
134. 134 Yang, M., Hogan, S.P., Mahalingam, S., Pope, S.M., Zimmermann, N., Fulkerson, P., et al. Eotaxin-2 and IL-5 cooperate in the lung to regulate IL-13 production and airway eosinophilia and hyperreactivity. J Allergy Clin Immunol 112 (2003), 935–943.
135. 135 Barnes, P.J., Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap syndromes. J Allergy Clin Immunol 136 (2015), 531–545.
136. 136 Fajt, M.L., Wenzel, S.E., Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care. J Allergy Clin Immunol 135 (2015), 299–310.
137. 137 LaPorte, S.L., Juo, Z.S., Vaclavikova, J., Colf, L.A., Qi, X., Heller, N.M., et al. Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system. Cell 132 (2008), 259–272.
138. 138 Campbell-Harding, G., Sawkins, H., Bedke, N., Holgate, S.T., Davies, D.E., Andrews, A.L., The innate antiviral response upregulates IL-13 receptor alpha2 in bronchial fibroblasts. J Allergy Clin Immunol 131 (2013), 849–855.
139. 139 Hunninghake, G.M., Soto-Quiros, M.E., Avila, L., Su, J., Murphy, A., Demeo, D.L., et al. Polymorphisms in IL13, total IgE, eosinophilia, and asthma exacerbations in childhood. J Allergy Clin Immunol 120 (2007), 84–90.
140. 140 Smith, S.G., Chen, R., Kjarsgaard, M., Huang, C., Oliveria, J.P., O'Byrne, P.M., et al. Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia. J Allergy Clin Immunol 137 (2015), 75–86.
141. 141 Fort, M.M., Cheung, J., Yen, D., Li, J., Zurawski, S.M., Lo, S., et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15 (2001), 985–995.
142. 142 Shin, H.W., Kim, D.K., Park, M.H., Eun, K.M., Lee, M., So, D., et al. IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis. J Allergy Clin Immunol 135 (2015), 1476–1485.e7.
143. 143 Stott, B., Lavender, P., Lehmann, S., Pennino, D., Durham, S., Schmidt-Weber, C.B., Human IL-31 is induced by IL-4 and promotes TH2-driven inflammation. J Allergy Clin Immunol 132 (2013), 446–454.e5.
144. 144 Cevikbas, F., Wang, X., Akiyama, T., Kempkes, C., Savinko, T., Antal, A., et al. A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: involvement of TRPV1 and TRPA1. J Allergy Clin Immunol 133 (2014), 448–460.
145. 145 Hartmann, K., Wagner, N., Rabenhorst, A., Pflanz, L., Leja, S., Forster, A., et al. Serum IL-31 levels are increased in a subset of patients with mastocytosis and correlate with disease severity in adult patients. J Allergy Clin Immunol 132 (2013), 232–235.
146. 146 Saenz, S.A., Taylor, B.C., Artis, D., Welcome to the neighborhood: epithelial cell-derived cytokines license innate and adaptive immune responses at mucosal sites. Immunol Rev 226 (2008), 172–190.
147. 147 Park, L.S., Martin, U., Garka, K., Gliniak, B., Di Santo, J.P., Muller, W., et al. Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: Formation of a functional heteromeric complex requires interleukin 7 receptor. J Exp Med 192 (2000), 659–670.
148. 148 Siracusa, M.C., Saenz, S.A., Wojno, E.D., Kim, B.S., Osborne, L.C., Ziegler, C.G., et al. Thymic stromal lymphopoietin-mediated extramedullary hematopoiesis promotes allergic inflammation. Immunity 39 (2013), 1158–1170.
149. 149 Cheng, D.T., Ma, C., Niewoehner, J., Dahl, M., Tsai, A., Zhang, J., et al. Thymic stromal lymphopoietin receptor blockade reduces allergic inflammation in a cynomolgus monkey model of asthma. J Allergy Clin Immunol 132 (2013), 455–462.
150. 150 Gauvreau, G.M., O'Byrne, P.M., Boulet, L.P., Wang, Y., Cockcroft, D., Bigler, J., et al. Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. N Engl J Med 370 (2014), 2102–2110.
151. 151 Wilson, S.R., The, L., Batia, L.M., Beattie, K., Katibah, G.E., McClain, S.P., et al. The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch. Cell 155 (2013), 285–295.
152. 152 Divekar, R., Kita, H., Recent advances in epithelium-derived cytokines (IL-33, IL-25, and thymic stromal lymphopoietin) and allergic inflammation. Curr Opin Allergy Clin Immunol 15 (2015), 98–103.
153. 153 Ying, G., Zhang, Y., Tang, G., Chen, S., Functions of thymic stromal lymphopoietin in non-allergic diseases. Cell Immunol 295 (2015), 144–149.
154. 154 Coelho, A.L., Hogaboam, C.M., Kunkel, S.L., Chemokines provide the sustained inflammatory bridge between innate and acquired immunity. Cytokine Growth Factor Rev 16 (2005), 553–560.
155. 155 Holmes, W.E., Lee, J., Kuang, W.J., Rice, G.C., Wood, W.I., Structure and functional expression of a human interleukin-8 receptor. Science 253 (1991), 1278–1280.
156. 156 Burke, S.M., Issekutz, T.B., Mohan, K., Lee, P.W., Shmulevitz, M., Marshall, J.S., Human mast cell activation with virus-associated stimuli leads to the selective chemotaxis of natural killer cells by a CXCL8-dependent mechanism. Blood 111 (2008), 5467–5476.
157. 157 Beigelman, A., Isaacson-Schmid, M., Sajol, G., Baty, J., Rodriguez, O.M., Leege, E., et al. Randomized trial to evaluate azithromycin's effects on serum and upper airway IL-8 levels and recurrent wheezing in infants with respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol 135 (2015), 1171–1178.e1.
158. 158 Center, D.M., Cruikshank, W., Modulation of lymphocyte migration by human lymphokines. I. Identification and characterization of chemoattractant activity for lymphocytes from mitogen-stimulated mononuclear cells. J Immunol 128 (1982), 2563–2568.
159. 159 Baier, M., Bannert, N., Werner, A., Lang, K., Kurth, R., Molecular cloning, sequence, expression, and processing of the interleukin 16 precursor. Proc Natl Acad Sci U S A 94 (1997), 5273–5277.
160. 160 Richmond, J., Tuzova, M., Cruikshank, W., Center, D., Regulation of cellular processes by interleukin-16 in homeostasis and cancer. J Cell Physiol 229 (2014), 139–147.
161. 161 Schmidt-Weber, C.B., Akdis, M., Akdis, C.A., TH17 cells in the big picture of immunology. J Allergy Clin Immunol 120 (2007), 247–254.
162. 162 Burgler, S., Ouaked, N., Bassin, C., Basinski, T.M., Mantel, P.Y., Siegmund, K., et al. Differentiation and functional analysis of human T(H)17 cells. J Allergy Clin Immunol 123 (2009), 588–595 e1-7.
163. 163 Hwang, S.Y., Kim, H.Y., Expression of IL-17 homologs and their receptors in the synovial cells of rheumatoid arthritis patients. Mol Cell 19 (2005), 180–184.
164. 164 McAleer, J.P., Kolls, J.K., Directing traffic: IL-17 and IL-22 coordinate pulmonary immune defense. Immunol Rev 260 (2014), 129–144.
165. 165 Manners, S., Alam, R., Schwartz, D.A., Gorska, M.M., A mouse model links asthma susceptibility to prenatal exposure to diesel exhaust. J Allergy Clin Immunol 134 (2014), 63–72.
166. 166 Nanzer, A.M., Chambers, E.S., Ryanna, K., Richards, D.F., Black, C., Timms, P.M., et al. Enhanced production of IL-17A in patients with severe asthma is inhibited by 1alpha,25-dihydroxyvitamin D3 in a glucocorticoid-independent fashion. J Allergy Clin Immunol 132 (2013), 297–304.e3.
167. 167 Chambers, E.S., Nanzer, A.M., Pfeffer, P.E., Richards, D.F., Timms, P.M., Martineau, A.R., et al. Distinct endotypes of steroid-resistant asthma characterized by IL-17A(high) and IFN-gamma(high) immunophenotypes: potential benefits of calcitriol. J Allergy Clin Immunol 136 (2015), 628–637.e4.
168. 168 Li, H., Chen, J., Huang, A., Stinson, J., Heldens, S., Foster, J., et al. Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. Proc Natl Acad Sci U S A 97 (2000), 773–778.
169. 169 Starnes, T., Broxmeyer, H.E., Robertson, M.J., Hromas, R., Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. J Immunol 169 (2002), 642–646.
170. 170 Starnes, T., Robertson, M.J., Sledge, G., Kelich, S., Nakshatri, H., Broxmeyer, H.E., et al. Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J Immunol 167 (2001), 4137–4140.
171. 171 Hymowitz, S.G., Filvaroff, E.H., Yin, J.P., Lee, J., Cai, L., Risser, P., et al. IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J 20 (2001), 5332–5341.
172. 172 Chan, Y.R., Chen, K., Duncan, S.R., Lathrop, K.L., Latoche, J.D., Logar, A.J., et al. Patients with cystic fibrosis have inducible IL-17(+)IL-22(+) memory cells in lung draining lymph nodes. J Allergy Clin Immunol 131 (2013), 1117–1129.
173. 173 Hasan, S.A., Eksteen, B., Reid, D., Paine, H.V., Alansary, A., Johannson, K., et al. Role of IL-17A and neutrophils in fibrosis in experimental hypersensitivity pneumonitis. J Allergy Clin Immunol 131 (2013), 1663–1673.
174. 174 Czarnowicki, T., Gonzalez, J., Shemer, A., Malajian, D., Xu, H., Zheng, X., et al. Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population. J Allergy Clin Immunol 136 (2015), 104–115.e7.
175. 175 Lantz, C.S., Boesiger, J., Song, C.H., Mach, N., Kobayashi, T., Mulligan, R.C., et al. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature 392 (1998), 90–93.
176. 176 Salter, B.M., Oliveria, J.P., Nusca, G., Smith, S.G., Watson, R.M., Comeau, M., et al. Thymic stromal lymphopoietin activation of basophils in patients with allergic asthma is IL-3 dependent. J Allergy Clin Immunol 136 (2015), 1636–1644.
177. 177 Honda, M., Yamamoto, S., Cheng, M., Yasukawa, K., Suzuki, H., Saito, T., et al. Human soluble IL-6 receptor: its detection and enhanced release by HIV infection. J Immunol 148 (1992), 2175–2180.
178. 178 Hirano, T., Taga, T., Nakano, N., Yasukawa, K., Kashiwamura, S., Shimizu, K., et al. Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proc Natl Acad Sci U S A 82 (1985), 5490–5494.
179. 179 Ullah, M.A., Revez, J.A., Loh, Z., Simpson, J., Zhang, V., Bain, L., et al. Allergen-induced IL-6 trans-signaling activates γδ T cells to promote type 2 and type 17 airway inflammation. J Allergy Clin Immunol 136 (2015), 1065–1073.
180. 180 Cherel, M., Sorel, M., Lebeau, B., Dubois, S., Moreau, J.F., Bataille, R., et al. Molecular cloning of two isoforms of a receptor for the human hematopoietic cytokine interleukin-11. Blood 86 (1995), 2534–2540.
181. 181 Paul, S.R., Schendel, P., The cloning and biological characterization of recombinant human interleukin 11. Int J Cell Cloning 10 (1992), 135–143.
182. 182 Bhatia, M., Davenport, V., Cairo, M.S., The role of interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with solid tumors, lymphoma, acute myeloid leukemia and bone marrow failure syndromes. Leuk Lymphoma 48 (2007), 9–15.
183. 183 Wan, B., Zhang, H., Fu, H., Chen, Y., Yang, L., Yin, J., et al. Recombinant human interleukin-11 (IL-11) is a protective factor in severe sepsis with thrombocytopenia: a case-control study. Cytokine 76 (2015), 138–143.
184. 184 Shen, L., Zhang, C., Wang, T., Brooks, S., Ford, R.J., Lin-Lee, Y.C., et al. Development of autoimmunity in IL-14alpha-transgenic mice. J Immunol 177 (2006), 5676–5686.
185. 185 Sahasrabuddhe, C.G., Morgan, J., Sharma, S., Mehta, S., Martin, B., Wright, D., et al. Evidence for an intracellular precursor for human B-cell growth factor. Proc Natl Acad Sci U S A 81 (1984), 7902–7906.
186. 186 Khan, F.A., Al-Jameil, N., Khan, M.F., Al-Rashid, M., Tabassum, H., Thyroid dysfunction: an autoimmune aspect. Int J Clin Exp Med 8 (2015), 6677–6681.
187. 187 Dinarello, C.A., Kim, S.H., IL-32, a novel cytokine with a possible role in disease. Ann Rheum Dis 65:suppl 3 (2006), iii61–iii64.
188. 188 Meyer, N., Zimmermann, M., Burgler, S., Bassin, C., Woehrl, S., Moritz, K., et al. IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis. J Allergy Clin Immunol 125 (2010), 858–865.e10.
189. 189 Meyer, N., Christoph, J., Makrinioti, H., Indermitte, P., Rhyner, C., Soyka, M., et al. Inhibition of angiogenesis by IL-32: possible role in asthma. J Allergy Clin Immunol 129 (2012), 964–973.e7.
190. 190 Droin, N., Solary, E., Editorial: CSF1R, CSF-1, and IL-34, a “menage a trois” conserved across vertebrates. J Leukoc Biol 87 (2010), 745–747.
191. 191 Wang, Y., Szretter, K.J., Vermi, W., Gilfillan, S., Rossini, C., Cella, M., et al. IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat Immunol 13 (2012), 753–760.
192. 192 Esaki, H., Ewald, D.A., Ungar, B., Rozenblit, M., Zheng, X., Xu, H., et al. Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection. J Allergy Clin Immunol 135 (2015), 153–163.
193. 193 Zimmermann, M., Koreck, A., Meyer, N., Basinski, T., Meiler, F., Burgler, S., et al. TWEAK and TNF-alpha cooperate in the induction of keratinocyte-apoptosis. J Allergy Clin Immunol 127 (2011), 200–207.
194. 194 Gao, L., Bin, L., Rafaels, N.M., Huang, L., Potee, J., Ruczinski, I., et al. Targeted deep sequencing identifies rare loss-of-function variants in IFNGR1 for risk of atopic dermatitis complicated by eczema herpeticum. J Allergy Clin Immunol 136 (2015), 1591–1600.
195. 195 Coccia, E.M., Severa, M., Giacomini, E., Monneron, D., Remoli, M.E., Julkunen, I., et al. Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur J Immunol 34 (2004), 796–805.
196. 196 Claudio, N., Dalet, A., Gatti, E., Pierre, P., Mapping the crossroads of immune activation and cellular stress response pathways. EMBO J 32 (2013), 1214–1224.
197. 197 Durbin, R.K., Kotenko, S.V., Durbin, J.E., Interferon induction and function at the mucosal surface. Immunol Rev 255 (2013), 25–39.
198. 198 Livingstone, M., Sikstrom, K., Robert, P.A., Uze, G., Larsson, O., Pellegrini, S., Assessment of mTOR-dependent translational regulation of interferon stimulated genes. PLoS One, 10, 2015, e0133482.
199. 199 Richer, M.J., Pewe, L.L., Hancox, L.S., Hartwig, S.M., Varga, S.M., Harty, J.T., Inflammatory IL-15 is required for optimal memory T cell responses. J Clin Invest 125 (2015), 3477–3490.
200. 200 Schmidt, N.W., Jin, F., Lande, R., Curk, T., Xian, W., Lee, C., et al. Liquid-crystalline ordering of antimicrobial peptide-DNA complexes controls TLR9 activation. Nat Mater 14 (2015), 696–700.
201. 201 Reder, A.T., Feng, X., Aberrant type i interferon regulation in autoimmunity: opposite directions in MS and SLE, shaped by evolution and body ecology. Front Immunol, 4, 2013, 281.
202. 202 Baraldo, S., Contoli, M., Bazzan, E., Turato, G., Padovani, A., Marku, B., et al. Deficient antiviral immune responses in childhood: distinct roles of atopy and asthma. J Allergy Clin Immunol 130 (2012), 1307–1314.
203. 203 Gielen, V., Sykes, A., Zhu, J., Chan, B., Macintyre, J., Regamey, N., et al. Increased nuclear suppressor of cytokine signaling 1 in asthmatic bronchial epithelium suppresses rhinovirus induction of innate interferons. J Allergy Clin Immunol 136 (2015), 177–188.e11.
204. 204 Shi, M., Zhu, J., Wang, R., Chen, X., Mi, L., Walz, T., et al. Latent TGF-beta structure and activation. Nature 474 (2011), 343–349.
205. 205 Butz, H., Racz, K., Hunyady, L., Patocs, A., Crosstalk between TGF-beta signaling and the microRNA machinery. Trends Pharmacol Sci 33 (2012), 382–393.
206. 206 Gutcher, I., Donkor, M.K., Ma, Q., Rudensky, A.Y., Flavell, R.A., Li, M.O., Autocrine transforming growth factor-beta1 promotes in vivo Th17 cell differentiation. Immunity 34 (2011), 396–408.
207. 207 Derynck, R., Akhurst, R.J., Differentiation plasticity regulated by TGF-beta family proteins in development and disease. Nat Cell Biol 9 (2007), 1000–1004.
208. 208 Biernacka, A., Dobaczewski, M., Frangogiannis, N.G., TGF-beta signaling in fibrosis. Growth Factors 29 (2011), 196–202.
209. 209 Sanjabi, S., Zenewicz, L.A., Kamanaka, M., Flavell, R.A., Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity. Curr Opin Pharmacol 9 (2009), 447–453.
210. 210 Habashi, J.P., Judge, D.P., Holm, T.M., Cohn, R.D., Loeys, B.L., Cooper, T.K., et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312 (2006), 117–121.
211. 211 Caraci, F., Spampinato, S., Sortino, M.A., Bosco, P., Battaglia, G., Bruno, V., et al. Dysfunction of TGF-beta1 signaling in Alzheimer's disease: perspectives for neuroprotection. Cell Tissue Res 347 (2012), 291–301.
212. 212 Meulmeester, E., Ten Dijke, P., The dynamic roles of TGF-beta in cancer. J Pathol 223 (2011), 205–218.
213. 213 Beppu, L.Y., Anilkumar, A.A., Newbury, R.O., Dohil, R., Broide, D.H., Aceves, S.S., TGF-beta1-induced phospholamban expression alters esophageal smooth muscle cell contraction in patients with eosinophilic esophagitis. J Allergy Clin Immunol 134 (2014), 1100–1107.e4.
214. 214 Rajan, J., Newbury, R.O., Anilkumar, A., Dohil, R., Broide, D.H., Aceves, S.S., Long-term assessment of esophageal remodeling in patients with pediatric eosinophilic esophagitis treated with topical corticosteroids. J Allergy Clin Immunol 137 (2015), 147–156.
215. 215 Akhurst, R.J., The paradoxical TGF-beta vasculopathies. Nat Genet 44 (2012), 838–839.
216. 216 Wakefield, L.M., Hill, C.S., Beyond TGFbeta: roles of other TGFbeta superfamily members in cancer. Nat Rev Cancer 13 (2013), 328–341.
217. 217 Carswell, E.A., Old, L.J., Kassel, R.L., Green, S., Fiore, N., Williamson, B., An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A 72 (1975), 3666–3670.
218. 218 Brown, S.D., Brown, L.A., Stephenson, S., Dodds, J.C., Douglas, S.L., Qu, H., et al. Characterization of a high TNF-alpha phenotype in children with moderate-to-severe asthma. J Allergy Clin Immunol 135 (2015), 1651–1654.